Harnessing Yarrowia lipolytica lipogenesis to create a platform for lipid and biofuel production J Blazeck, A Hill, L Liu, R Knight, J Miller, A Pan, P Otoupal, HS Alper Nature communications 5 (1), 3131, 2014 | 575 | 2014 |
Overcoming gene-delivery hurdles: physiological considerations for nonviral vectors AB Hill, M Chen, CK Chen, BA Pfeifer, CH Jones Trends in biotechnology 34 (2), 91-105, 2016 | 170 | 2016 |
Metabolic engineering of Yarrowia lipolytica for itaconic acid production J Blazeck, A Hill, M Jamoussi, A Pan, J Miller, HS Alper Metabolic engineering 32, 66-73, 2015 | 146 | 2015 |
Design of pH sensitive binding proteins from the hyperthermophilic Sso7d scaffold N Gera, AB Hill, DP White, RG Carbonell, BM Rao PloS one 7 (11), e48928, 2012 | 78 | 2012 |
Phenotypic variation during biofilm formation: implications for anti-biofilm therapeutic design M Beitelshees, A Hill, CH Jones, BA Pfeifer Materials 11 (7), 1086, 2018 | 73 | 2018 |
Expanding the metabolic engineering toolbox with directed evolution J Abatemarco, A Hill, HS Alper Biotechnology journal 8 (12), 1397-1410, 2013 | 51 | 2013 |
Directed vaccination against pneumococcal disease Y Li, A Hill, M Beitelshees, S Shao, JF Lovell, BA Davidson, PR Knight III, ... Proceedings of the National Academy of Sciences 113 (25), 6898-6903, 2016 | 48 | 2016 |
Improving global vaccine accessibility AB Hill, C Kilgore, M McGlynn, CH Jones Current opinion in biotechnology 42, 67-73, 2016 | 45 | 2016 |
Comprehensive vaccine design for commensal disease progression CH Jones, G Zhang, R Nayerhoda, M Beitelshees, A Hill, P Rostami, Y Li, ... Science Advances 3 (10), e1701797, 2017 | 32 | 2017 |
In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector Y Li, M Beitelshees, L Fang, A Hill, MK Ahmadi, M Chen, BA Davidson, ... Science Advances 2 (7), e1600264, 2016 | 27 | 2016 |
Contemporary approaches for nonviral gene therapy CH Jones, A Hill, M Chen, BA Pfeifer Discovery medicine 19 (107), 447, 2015 | 23 | 2015 |
Engineering a Next-Generation Glycoconjugate-Like Streptococcus pneumoniae Vaccine AB Hill, M Beitelshees, R Nayerhoda, BA Pfeifer, CH Jones ACS infectious diseases 4 (11), 1553-1563, 2018 | 21 | 2018 |
Yarrowia lipolytica as a cell factory for oleochemical biotechnology KA Markham, L Cordova, A Hill, HS Alper Consequences of microbial interactions with hydrocarbons, oils, and lipids …, 2017 | 19 | 2017 |
Vaccine delivery and immune response basics A Hill, M Beitelshees, BA Pfeifer Vaccine Delivery Technology: Methods and Protocols, 1-8, 2021 | 13 | 2021 |
Pressing diseases that represent promising targets for gene therapy M Beitelshees, A Hill, P Rostami, CH Jones, BA Pfeifer Discovery medicine 24 (134), 313, 2017 | 12 | 2017 |
Scaffold diversification enhances effectiveness of a superlibrary of hyperthermophilic proteins M Hussain, N Gera, AB Hill, BM Rao ACS Synthetic Biology 2 (1), 6-13, 2013 | 10 | 2013 |
Compositions and methods for lipid production J Blazeck, A Hill, L Liu, H Alper US Patent 9,896,691, 2018 | 9 | 2018 |
Harnessing Yarrowia lipolytica lipogenesis to create a platform for lipid and biofuel production. Nat Commun 2014; 5: 3131 J Blazeck, A Hill, L Liu, R Knight, J Miller, A Pan | 6 | |
Liposomal Dual Delivery of Both Polysaccharide and Protein Antigens R Nayerhoda, A Hill, BA Pfeifer Vaccine Delivery Technology: Methods and Protocols, 477-487, 2021 | 5 | 2021 |
Design variation of a dual-antigen liposomal vaccine carrier system R Nayerhoda, A Hill, M Beitelshees, C Jones, B Pfeifer Materials 12 (17), 2809, 2019 | 3 | 2019 |